 TORONTO, Aug. 17, 2021 PRNewswire - Braxia Scientific Corp. Braxia Scientific, or the Company, CSE: BRAX OTC: BRAXF FWB: 496, a medical research company with clinics providing innovative ketamine treatments for persons with depression and related disorders, is pleased to announce its managements participation at the upcoming H.C. Wainwright 23rd Annual Global Investment Conference. 